Synthetic analogues of netropsin and distamycin - Synthesis of a new pyridine and carbocyclic analogues of the pyrrolecarbox-amide antitumour antibiotics

Acta Biochimica Polonica

Volumn 45, Issue 1, 1998, Pages 41-57

  Bartulewicz, Danuta ^a   Bielawski, Krzysztof ^a   Markowska, Agnieszka ^a   Zwierz, Krzysztof ^a   Pućkowska, Anna ^a   Rózański, Andrzej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Distamycin; Drug design; Molecular modelling; Netropsin

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CARBOXYLIC ACID; CONGOCIDINE; DISTAMYCIN A; DRUG DERIVATIVE; PYRIDINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; COMPUTER SIMULATION; CONFORMATION; SYNTHESIS;

ACIDS, CARBOCYCLIC; ANTIBIOTICS, ANTINEOPLASTIC; COMPUTER SIMULATION; DISTAMYCINS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; NETROPSIN; PYRIDINES;

EID: 0031604991     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Gniazdowski, M. (1985) Molekularne mechanizmy hamowania syntezy RNA. Inhibitory oddziaływuja̧ce z DNA. Post. Biochem. 31, 53-86 (in Polish).
2. Hartley, J.A., Lown, J.W., Mattes, W.B. & Kohn, K.W. (1988) DNA sequence specificity of antitumor agents: Oncogenes as possible targets for cancer therapy. Acta Oncol. 27, 503-506.
3. Hurley, L.H. (1989) DNA and associated targets for drug design. J. Med. Chem. 32, 2027-2033.
4. Dervan, P.B. (1986) Design of sequence-specific DNA binding molecules. Science 232, 464-471.
5. Bains, W. (1989) Disease, DNA and diagnosis. New Scientist 11, 48-51.
6. Lown, J.W. (1992) Lexitropsins in antiviral drug development. Antiviral. Res. 17, 179-196.
7. Nelsen, P.E. (1991) Sequence-selective DNA recognition by synthetic ligands. Bioconjugate Chem. 2, 1-12.
8. Cory, M. (1995) DNA/minor-groove binding compounds as antitumor agents; in Cancer Chemotherapeutic Agents (Foye, W.O., ed.) pp. 320-324, Am. Chem. Soc., Washington.
9. Fontana, M., Lestingi, M., Mondello, Ch., Braghetti, A., Montecucco, A. & Ciarrocchi, G. (1992) DNA binding properties of FCE24517, an electrophilic distamycin analogue. Anti-Cancer Drug Design 7, 131-141.
10. Mattes, W.B., Hartley, J.A., Kohn, K.W. & Matheson, D.W. (1988) GC-rich regions hi genomes as targets for DNA alkylation. Carcinogenesis. 9, 2065-2072.
11. Kopka, M.L., Yoon, C., Goodsell, D., Pjura, P. & Dickerson, R.E. (1985) The molecular origin of DNA-drug specificity of netropsin and distamycin. Proc. Natl. Acad. Sci. U.S.A. 82, 1376-1380.
12. Neidle, S., Pearl, L.H. & Skelly, J.V. (1987) DNA structure and perturbation by drug binding. Biochem. J. 243, 1-13.
13. Wade, W. & Dervan, P.B. (1987) Alteration of the sequence specificity of distamycin on DNA by replacement of an N-methylpyrrolecarboxamide with pyridine-2-carboxamide. J. Am. Chem. Soc. 109, 1574-1575.
14. Lown, J.W. (1988) Lexitropsins: Rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes. Anti-Cancer Drug Design 3, 25-40.
15. Rajagopalan, M., Rao, K.E., Ayyer, J. & Sasisekharan, V. (1987) Synthesis of a distamycin analogue: Tris(m-benzamido) compound. Indian J. Chem. 26B, 1021-1024.
16. Dasgupta, D., Rajagopalan, M. & Sasisekharan, V. (1986) DNA-binding characteristics of a synthetic analogue of distamycin. Biochem. Biophys. Res. Commun. 140, 626-631.
17. Rao, K.E. & Sasisekharan, V. (1990) Synthesis of distamycin and netropsin analogues: Part III. Biologically active analogues of tris(m-benzamido) compound. Indian J. Chem. 29B, 508-513.
18. Broggini, M., Coley, H.M., Mongelli, N., Pesenti, E., Wyatt, M.D., Hartley, J.H. & Dincalci, M. (1995) DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 245 17), a benzoyl nitrogen mustard derivative of distamycin. Nucleic Acids Res. 23, 81-87.
19. Baker, B.F. & Dervan, P.B. (1989) Sequence-specific cleavage of DNA by N-bromoacetyl-distamycin. Product and kinetic analyses. J. Am. Chem. Soc. 111, 2700-2712.
20. HyperChem, version 3.0. Autodesk Inc., 2320 Marinship Way, Sausalito, CA 94965.
21. Aped, P. & Allinger, N.L. (1992) A molecular mechanics study of cyclopropanes within the MM2 and MM3 force fields. J. Am. Chem. Soc. 114, 1-16.
22. Weiner, S.J., Kollman, P.A., Nguyen, D.T. & Case, D.A. (1986) An all atom force field for simulations of proteins and nucleic acids. J. Comput. Chem. 7, 230-252.
23. Kazicyna, L.A. & Kupletska, N.B. (1974) Metody spektroskopowe wyznaczania struktury zwia̧zków organicznych. PWN, Warszawa (in Polish).
24. Szafran, M. & Dega-Szafran, Z. (1988) Określanie struktury zwia̧zków organicznych metodami spektroskopowymi. Tablice i ćwiczenia. PWN, Warszawa (in Polish).
25. Polaczkowa, W. (1954) in Preparatyka organiczna, pp. 589-591, PWN, Warszawa (in Polish).
26. Stevens, M. (1989) AIDS drugs act to disrupt nucleic acids. New Scientist 11, 37-42.
27. Zakrzewska, K., Lavery, R. & Pullmann, B. (1984) Theoretical studies of the selective binding to DNA of two nonintercalating ligands: Netropsin and SN 18071. Nucleic Acids Res. 11, 8825-8839.
28. 3-6, in complex with 5′-TGACT-3′ sites by two-dimensional NMR. J. Am. Chem. Soc. 115, 9900-9906.
29. Bialer, M., Yagen, B., Mechoulam, R. & Becker, Y. (1979) Structure-activity relationships of pyrrole amidine antiviral antibiotics. 1. Modifications of the alkylamidine side chain. J. Med. Chem. 22, 1296-1302.
30. 2 determined by two-dimensional NMR. J. Am. Chem. Soc. 112, 1393-1399.
31. Grootenhuis, P.D.J., Kollman, P.A., Seibel, G.L., DesJarlais, R.L. & Kuntz, I.D. (1990) Computerised selection of potential DNA binding compounds. Anti-Cancer Drug Design 5, 237-242.
32. Goodsell, D. & Dickerson, E. (1986) Isohelical analysis of DNA groove-binding drugs. J. Med. Chem. 29, 727-733.
33. Rao, K.E., Zimmermann, J. & Lown, J.W. (1991) Sequence-selective DNA binding by bis-JV-methylpyrrole dipeptides: An analysis by MPE footprinting and force field calculations. J. Org. Chem. 56, 786-797.
34. Lee, H.H., Boyd, M., Gravatt, G.L. & Denny, W.A. (1991) Pyrazole analogues of the bispyrrolecarboxamide anti-tumour antibiotics: Synthesis, DNA binding and anti-tumour properties. Anti-Cancer Drug Design 6, 501-517.
35. Boger, D.L. & Johnson, D.S. (1995) CC-1065 and the duocarmycins: Unraveling the keys to a new class of naturally derived DNA alkylating agents. Proc. Natl. Acad. Sci. U.S.A. 92, 3642-3649.
36. Taylor, J.S., Schultz, P.G. & Dervan, P.B. (1984) DNA affinity cleaving: Sequence specific cleavage of DNA by distamycin-EDTA-Fe(II) and EDTA-distamycin-Fe(II). Tetrahedron 40, 457-464.
37. Bailly, C., D'Hooghe, M.C., Lantoine, D., Fournier, C., Hecquet, B., Fosse, P., Saucier, J.M., Colson, P., Houssier, C. & Henichart, J.P. (1992) Biological activity and molecular interaction of a netropsin-acridine hybrid ligand with chromatin and topoisomerase II. Biochem. Pharmacol. 43, 457-466.
38. Semmelhack, M.F. & Gallagher, J.J. (1994) The effect on DNA cleavage potency of tethering a simple cyclic enediyne to a netropsin analogue. J. Org. Chem. 59, 4357-4359.
39. 2 as determined by two-dimensional nuclear magnetic resonance spectroscopy. J. Am. Chem. Soc. 117, 9941-9950.
40. Rao, K.E., Bathini, Y. & Lown, J.W. (1990) Synthesis of novel thiazole-containing DNA minor groove binding oligopeptides related to the antibiotic distamycin. J. Org. Chem. 55, 728-737.
41. Grochowskij, S.L., Zuze, A.L. & Gottich, B.P. (1982) Ligandy obladajuszcze srodstwom k opredelennym posledowatelnostjam par osnowanij DNK. VII. Sintez anałogow distamicina A, sostojaszczich iz dwuch i trech N-izoamiłpirrołkarboksamidnych fragmentow, i analoga, soderżajuszczego metiłamidnye swjazi w molekule. Bioorg. Chim. 8, 1070-1076 (in Russian).